Safety and Outcomes With Combination Therapy With Sarilumab and Baricitinib for Severe COVID-19 Respiratory Infection in Cancer Patients

Safety and Outcomes With Combination Therapy With Sarilumab and Baricitinib for Severe COVID-19 Respiratory Infection in Cancer Patients

Objectives This study aims to describe the clinical outcomes of combination therapy with sarilumab and baricitinib for severe novel Coronavirus-19 (COVID-19) infection in cancer patients. With this study, we aim to evaluate the role of expanded immunotherapy for severely ill patients with COVID-19 r...

Full description

Bibliographic Details
Main Authors: Ana Paula Velez, Guy Handley, Austin Morison, Ju Hee Katzman, Olga kinkhova, Rod Quiltz, John Greene, Yanina Pasikhova
Format: Article
Language:English
Published: SAGE Publishing 2023-09-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/10732748231205864

Internet

https://doi.org/10.1177/10732748231205864

Similar Items